Qiyu Biotech

About:

Qiyu Biotech is an innovative macromolecular drug developer.

Top Investors: Oriza Holdings, BOCOM International, Shanghai Pudong Science and Technology Investment, Longmen Capital, Leaguer Group

Description:

Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.